TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
QuiaPEG Pharmaceuticals AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
21 |
| Financial expenses |
2
|
5
|
19 |
| Earnings before taxes |
-1,173
|
-1,219
|
-1,457 |
| EBITDA |
-823
|
-911
|
-1,224 |
| Total assets |
1,887
|
1,934
|
1,827 |
| Current assets |
67
|
165
|
119 |
| Current liabilities |
431
|
1,412
|
1,673 |
| Equity capital |
1,456
|
517
|
118 |
| - share capital |
14
|
14
|
15 |
| Employees (average) |
3
|
4
|
5 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
77.2%
|
26.7%
|
6.5% |
| Turnover per employee |
0
|
0
|
4 |
| Profit as a percentage of turnover | -6938.1% | ||
| Return on assets (ROA) |
-62.1%
|
-62.8%
|
-78.7% |
| Current ratio |
15.5%
|
11.7%
|
7.1% |
| Return on equity (ROE) |
-80.6%
|
-235.8%
|
-1234.7% |
| Change turnover |
0
|
-19
|
-161 |
| Change turnover % |
-100%
|
-88% | |
| Chg. No. of employees |
-1
|
-1
|
2 |
| Chg. No. of employees % |
-25%
|
-20%
|
67% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.